Research ArticleDown Syndrome

Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

See allHide authors and affiliations

Science Translational Medicine  18 Nov 2009:
Vol. 1, Issue 7, pp. 7ra17
DOI: 10.1126/scitranslmed.3000258

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Down syndrome (trisomy 21) is the most common cause of mental retardation in children and leads to marked deficits in contextual learning and memory. In rodents, these tasks require the hippocampus and are mediated by several inputs, particularly those originating in the locus coeruleus. These afferents mainly use norepinephrine as a transmitter. To explore the basis for contextual learning defects in Down syndrome, we examined the Ts65Dn mouse model. These mice, which have three copies of a fragment of mouse chromosome 16, exhibited significant deficits in contextual learning together with dysfunction and degeneration of locus coeruleus neurons. However, the postsynaptic targets of innervation remained responsive to noradrenergic receptor agonists. Indeed, despite advanced locus coeruleus degeneration, we were able to reverse contextual learning failure by using a prodrug for norepinephrine called l-threo-3,4-dihydroxyphenylserine, or xamoterol, a β1-adrenergic receptor partial agonist. Moreover, an increased gene dosage of App, in the context of Down syndrome, was necessary for locus coeruleus degeneration. Our findings raise the possibility that restoring norepinephrine-mediated neurotransmission could reverse cognitive dysfunction in Down syndrome.


  • Present address: Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA.

  • Present address: Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.

View Full Text

Stay Connected to Science Translational Medicine